Skip to search formSkip to main contentSkip to account menu

MDL 646

Known as: MDL-646 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mexiprostil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Gastric antisecretory and cytoprotective activity of MDL 646, a 16-methyl-16-methoxy prostaglandin E1 analog in man.
MDL 646 is a 16-methyl-16-methoxy PGE analog with gastric antisecretory and cytoprotective activity in rats following oral… 
1987
1987
An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a tablet and lyovial formulation.
The effects of single doses of 800 micrograms and 1200 micrograms of the new alprostadil analogue (prostaglandin E1 16-methyl-16… 
1986
1986
[Does simultaneous administration of a PGE1 analog prevent indomethacin damage to human gastric mucosa? An endoscopic double-blind study].
The influence on gastroduodenal mucosa of indomethacin (50 mg t.i.d.) administration for 6 days was investigated in 7 healthy… 
1984
1984
Studies on the luteolytic activity of MDL-646, a new gastroprotective PGE1 analogue, in the hamster.
1984
1984
MDL-646, a new synthetic E1-prostaglandin with local protective effects on the gastric mucosa.
1983
1983
Action of MDL 646, a new synthetic prostaglandin, on gastric acid secretion of some experimental animals.
The new synthetic prostaglandin 11,15-dihydroxy-16-methyl-16-methoxy-9-oxo-prost-13-en-1-oic acid,methyl ester (8 alpha,11 alpha… 
1983
1983
Effect of MDL 646, a new synthetic prostaglandin, on gastroesophageal motility of the rat.
Compound marked MDL 646, a synthetic prostaglandin belonging to the 16-methyl-16-methoxy PGE1 series was tested for its motor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)